What are the potential causes of elevated alanine aminotransferase (ALT) in a 16-year-old girl?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated ALT in a 16-Year-Old Girl

In a 16-year-old girl with elevated ALT, nonalcoholic fatty liver disease (NAFLD) is the most common cause, followed by viral hepatitis (particularly hepatitis B and C), autoimmune hepatitis, medication-induced liver injury, and Wilson disease—all of which require systematic evaluation given the higher prevalence of autoimmune conditions and Wilson disease in adolescent females. 1, 2, 3

Understanding ALT Specificity in Adolescents

  • ALT is the most liver-specific enzyme because it exists primarily in hepatocytes with minimal presence in cardiac muscle, skeletal muscle, or red blood cells, making its elevation highly indicative of hepatocellular damage. 1, 2, 3
  • Normal ALT ranges for females are significantly lower than commercial laboratory cutoffs: 19-25 IU/L for adult women, with pediatric ranges being even lower at 35 IU/L after 18 months of age. 1, 4
  • This means that even modest elevations in a 16-year-old girl are more clinically significant than the same absolute value in an adult male. 1, 4

Most Common Causes by Frequency

Nonalcoholic Fatty Liver Disease (NAFLD)

  • NAFLD is the leading cause of elevated ALT in adolescents, affecting 20-30% of the general population and up to 70% in obese individuals. 2, 3, 5
  • Characterized by an AST:ALT ratio <1, which distinguishes it from alcoholic liver disease. 2, 3
  • Associated with metabolic syndrome components including obesity, insulin resistance, hypertension, and dyslipidemia. 6, 1, 7

Viral Hepatitis

  • Hepatitis B and C are common causes in adolescents, particularly those with risk factors including maternal transmission, blood transfusions, or high-risk behaviors. 1, 5, 7
  • Hepatitis B affects approximately 17% of patients with persistently elevated ALT in referral populations. 5
  • Hepatitis C accounts for 4% of cases with persistently elevated ALT. 5

Autoimmune Hepatitis

  • Autoimmune hepatitis is particularly important in adolescent females, accounting for 13% of cases with persistently elevated ALT. 5
  • This condition disproportionately affects young women and can present with gradual ALT increases. 1, 5
  • Typically shows higher elevations and elevated autoantibodies (ANA, anti-smooth muscle antibody). 1, 2

Medication-Induced Liver Injury

  • Accounts for 8-11% of cases with elevated liver enzymes. 1, 7
  • Requires comprehensive review of all prescription medications, over-the-counter drugs, herbal supplements, and dietary supplements. 1, 2

Wilson Disease

  • Must be suspected in any patient <40 years with unexplained hepatocellular injury, accounting for 1% of cases. 2, 5
  • Characterized by modest rises in aminotransferases and normal or markedly subnormal alkaline phosphatase. 2
  • Requires urgent evaluation as it is a treatable condition that can lead to fulminant hepatic failure if missed. 2

Initial Diagnostic Algorithm

Immediate Laboratory Testing

  • Complete liver panel: AST, ALT, alkaline phosphatase, GGT, total and direct bilirubin, albumin, and prothrombin time/INR. 1, 2, 3
  • Viral hepatitis serologies: HBsAg, anti-HBc IgM, and anti-HCV antibody. 1, 2, 3
  • Metabolic parameters: Fasting glucose or HbA1c, fasting lipid panel, blood pressure, and waist circumference to assess for metabolic syndrome. 1, 7
  • Autoimmune markers: ANA, anti-smooth muscle antibody (ASMA), and immunoglobulin G levels given the higher prevalence of autoimmune hepatitis in adolescent females. 1, 2
  • Iron studies: Ferritin and transferrin saturation to screen for hereditary hemochromatosis. 1, 7
  • Ceruloplasmin level to evaluate for Wilson disease, particularly important in this age group. 1, 2
  • Thyroid function tests to rule out hypothyroidism as a cause of transaminase elevation. 1, 7, 8
  • Creatine kinase to exclude muscle injury, especially if the patient engages in intensive exercise. 1, 2, 3

Initial Imaging

  • Abdominal ultrasound is the first-line imaging test with 84.8% sensitivity and 93.6% specificity for detecting moderate to severe hepatic steatosis. 1, 2, 3
  • Can identify structural causes including biliary obstruction, focal liver lesions, and portal hypertension features. 1, 2

Severity Classification and Management

Mild Elevation (<5× Upper Limit of Normal)

  • Repeat liver enzymes in 2-4 weeks to establish trend and direction of change. 1, 3
  • If values normalize or decrease, continue monitoring every 4-8 weeks until stabilized. 1
  • If values remain elevated, proceed with comprehensive evaluation as outlined above. 1, 3

Moderate Elevation (5-10× Upper Limit of Normal)

  • Requires prompt but not emergent evaluation with repeat testing within 2-5 days. 1, 3
  • Intensify evaluation for underlying causes including viral hepatitis, autoimmune hepatitis, and medication-induced liver injury. 1, 3

Severe Elevation (>10× Upper Limit of Normal)

  • Requires urgent hepatology referral within 2-3 days. 1, 3
  • Immediate evaluation for acute ischemic hepatitis, acute drug-induced liver injury, acute viral hepatitis, or acute biliary obstruction. 1, 9

Risk Stratification for Advanced Fibrosis

  • Calculate FIB-4 score using age, ALT, AST, and platelet count to determine need for hepatology referral. 1, 2, 3
  • A score >2.67 indicates high risk for advanced fibrosis and warrants hepatology referral. 1, 2, 3
  • A score <1.3 (<2.0 if age >65) indicates low risk with negative predictive value ≥90%. 1, 2

When to Refer to Hepatology

  • ALT increases to >5× upper limit of normal (>125 IU/L for females). 1, 2, 3
  • Bilirubin increases to >2× upper limit of normal. 1, 2, 3
  • Evidence of synthetic dysfunction (low albumin, prolonged PT/INR). 1, 2, 3
  • ALT remains elevated for ≥6 months without identified cause. 1, 2, 3
  • Suspicion for autoimmune hepatitis or Wilson disease, both of which require specialized management. 1, 2

Critical Pitfalls to Avoid

  • Do not assume NAFLD without excluding other causes, particularly autoimmune hepatitis and Wilson disease in this age group. 2, 5
  • Do not overlook medication history including over-the-counter drugs, herbal supplements, and dietary supplements. 1, 2, 7
  • Do not miss Wilson disease by failing to check ceruloplasmin in any patient <40 years with unexplained hepatocellular injury. 2, 5
  • Do not attribute severe ALT elevation (≥5× ULN) to NAFLD alone, as this level is rare in NAFLD and usually indicates another cause. 1, 2
  • Do not assume normal ALT excludes liver disease, as up to 10% of patients with advanced fibrosis may have normal ALT using conventional thresholds. 1, 2
  • Recent intensive exercise can cause acute ALT elevation that may be mistaken for liver injury; checking creatine kinase differentiates muscle from liver origin. 1, 2, 3

References

Guideline

Evaluation and Management of Mildly Elevated Transaminases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatocellular Injury Pattern Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Liver Enzymes: Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do?

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2009

Research

Blood alanine aminotransferase levels >1,000 IU/l - causes and outcomes.

Clinical medicine (London, England), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.